I try to watch as few ads and Public Service Announcements as possible, and I admit I haven’t seen the new video f…
JDRF
JDRF Announces Two Partnerships to Develop Pumpable Glucagon for Artificial Pancreas Systems
JDRF has announced a two partnerships to support the development soluble glucagon formulations—an important step toward …
JDRF and Tandem Team Up to Develop Dual Chamber Infusion Pump as a Step Toward the Artificial Pancreas
JDRF and Tandem Diabetes Care, the company behind the t:slim insulin pump, have teamed up to develop a dual-chamber infu…
JDRF Research Updates at EASD
The European Association for the Study of Diabetes (EASD) annual meeting is being held in Berlin right now, and yesterda…
Dexcom to Develop a “Smart Transmitter” as Part of JDRF Artificial Pancreas Project
JDRF and Dexcom announced that they have formed a partnership whose goal is to accelerate the development of a novel wir…
JDRF Research Summit: Toward a Cure and Better Living with Type 1 Diabetes
On Feb. 18 I moderated the JDRF Capitol Chapter’s second annual Research Summit on Type 1 Diabetes...…
First US Artificial Pancreas Outpatient Trial Approved by FDA
The U.S. Food and Drug Administration (FDA) has approved the first outpatient artificial pancreas trial in the United St…
Can Metformin Reduce Cardiovascular Risk in Type 1 Diabetes Patients?
JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes in the REMOVAL study, to test whether m…
FDA Issues Draft Guidance for the Development and Approval of the Artificial Pancreas
The U.S. Food and Drug Administration (FDA) issued draft guidance designed to help investigators and manufacturers as th…
Diabetes’ JDRF Tries Shock Ad to Push the FDA
This is not a story about statistics, yet I have to start there. It is not a story about a shocking ad that ran in the N…
